JPMorgan Chase & Co. Raises Stake in National Research Co. (NASDAQ:NRC)

JPMorgan Chase & Co. increased its holdings in shares of National Research Co. (NASDAQ:NRC) by 8.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,194 shares of the company’s stock after purchasing an additional 1,373 shares during the period. JPMorgan Chase & Co. owned approximately 0.07% of National Research worth $393,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the stock. Principal Financial Group Inc. purchased a new position in shares of National Research in the 3rd quarter valued at about $248,000. Barclays PLC increased its holdings in National Research by 65.6% in the 3rd quarter. Barclays PLC now owns 51,331 shares of the company’s stock worth $1,175,000 after acquiring an additional 20,331 shares in the last quarter. Geode Capital Management LLC raised its position in National Research by 3.2% during the third quarter. Geode Capital Management LLC now owns 420,733 shares of the company’s stock worth $9,619,000 after acquiring an additional 13,039 shares during the period. State Street Corp lifted its holdings in National Research by 4.0% during the third quarter. State Street Corp now owns 363,438 shares of the company’s stock valued at $8,351,000 after purchasing an additional 14,144 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new stake in shares of National Research during the third quarter worth about $88,000. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Down 1.1 %

NASDAQ NRC opened at $16.33 on Thursday. The business has a fifty day moving average price of $18.06 and a 200 day moving average price of $20.14. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The company has a market cap of $383.36 million, a P/E ratio of 14.45 and a beta of 0.53. National Research Co. has a one year low of $15.90 and a one year high of $42.00.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 18.78% and a return on equity of 67.40%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.